GenSci136
/ Gensciences
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
January 27, 2026
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
New P1 trial • Immunology
March 25, 2026
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology
October 02, 2026
Translational Preclinical Evaluation of GenSci136, a Long-Acting Dual B-Cell-Activating Factor (BAFF)/A Proliferation-Inducing Ligand (APRIL) Inhibitor, in Experimental Lupus Nephritis
(KIDNEY WEEK 2026)
- "In cynomolgus monkeys, single-dose GenSci136 showed sustained systemic exposure and longer mean residence time than telitacicept, with prolonged reductions in IgM, IgA, and IgG. Conclusion GenSci136 suppresses pathogenic humoral immunity and mitigates immune-complex–mediated renal injury across complementary preclinical models. Its sustained pharmacologic activity supports further clinical development for LN and other immune-complex–mediated kidney diseases."
Preclinical • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
March 18, 2026
Mechanistic and Translational Preclinical Evaluation of GenSci136, a Long-Acting Dual BAFF/APRIL Inhibitor, in Systemic Lupus Erythematosus
(EULAR 2026)
- "In vivo efficacy was assessed in female MRL/MpJ-Faslpr/J (MRL/lpr) mice randomized to receive vehicle, prednisone, or GenSci136 at multiple dose levels for 14 weeks. Image(s), graphic(s), or table(s) GenSci136 reduced total anti-dsDNA antibodies, improved UACR, and attenuated renal pathology in the MRL/lpr spontaneous lupus mouse model. Exploratory PK/PD assessment of GenSci136 with telitacicept as reference drug at 3 mg/kg dose in cynomolgus monkeys."
IO biomarker • Preclinical • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
1 to 4
Of
4
Go to page
1